Implanet S.A. (EPA:ALIMP)
France · Delayed Price · Currency is EUR 0.1650
+0.0036 (2.23%)
Aug 3, 2026, 11:53 AM CET
Implanet Revenue
In the year 2025, Implanet had annual revenue of 12.47M EUR with 102.30% growth. Implanet had revenue of 6.67M in the half year ending December 31, 2025, with 109.66% growth.
Revenue
12.47M
Revenue Growth
+102.30%
P/S Ratio
1.86
Revenue / Employee
271.17K
Employees
46
Market Cap
23.21M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 12.47M | 6.31M | 102.30% |
| Dec 31, 2024 | 6.17M | 1.06M | 20.74% |
| Dec 31, 2023 | 5.11M | -5.45M | -51.62% |
| Dec 31, 2022 | 10.56M | 4.42M | 71.91% |
| Dec 31, 2021 | 6.14M | 2.25M | 57.76% |
| Dec 31, 2020 | 3.89M | -3.52M | -47.46% |
| Dec 31, 2019 | 7.41M | 687.00K | 10.22% |
| Dec 31, 2018 | 6.72M | -1.12M | -14.30% |
| Dec 31, 2017 | 7.84M | 16.00K | 0.20% |
| Dec 31, 2016 | 7.83M | 1.17M | 17.61% |
| Dec 31, 2015 | 6.65M | -385.04K | -5.47% |
| Dec 31, 2014 | 7.04M | 348.03K | 5.20% |
| Dec 31, 2013 | 6.69M | 43.59K | 0.66% |
| Dec 31, 2012 | 6.65M | 2.13M | 47.05% |
| Dec 31, 2011 | 4.52M | 1.80M | 66.00% |
| Dec 31, 2010 | 2.72M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Guerbet | 798.67M |
| Eurobio Scientific Société anonyme | 168.60M |
| Biosynex | 95.19M |
| Diagnostic Medical Systems | 52.86M |
| Median Technologies | 23.47M |
| Novacyt | 22.96M |
| Bluelinea Société Anonyme | 11.12M |
| Mauna Kea Technologies | 8.91M |